Targeting the Lymphocyte-Activation Gene-3 (LAG-3) Immune Checkpoint in Patients With Cancer: Awareness and Confidence Among Oncology Healthcare Professionals

This poster, presented at the Society of Immunotherapy for Cancer Annual Meeting 2022, illustrates gaps in awareness of and confidence in using LAG-3 therapies for cancer among healthcare professionals.

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.


Cookie Settings